The clinical trials unit at Caulfield Hospital specialises in new treatments for Alzheimer’s disease.
Our Alzheimer's trials
Our main focus is on new medications for Alzheimer’s disease, both disease modifying drugs and symptomatic therapies. There are many treatments under development and we are usually recruiting interested patients into new studies.
Our team consists of doctors, nurses, neuropsychologists, and clinical trials coordinators with expertise in clinical trials for people with cognitive problems, including various types of dementia and neurodegenerative disorders.
Back row (L-R): Jenny Bortoli, Fenny Muliadi, Jenny Ung
Front row: Sue Dal Sasso, Maree Mastwyk
Accessing Alzheimer's clinical trials
In order to be eligible to enter a clinical trial, participants need to have a formal diagnosis of Alzheimer’s disease or mild cognitive impairment due to Alzheimer’s. The diagnosis is usually made by a specialist, often a geriatrician, psychogeriatrician, neurologist or psychiatrist. Our service does not provide diagnostic cognitive assessments.